Clinical Trial Update: Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting [Phase 4]

View source ↗

Summary

Phase 4 trial comparing aprepitant to ondansetron in preoperative triple-therapy for postoperative nausea and vomiting; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nausea
• Postoperative Nausea and Vomiting

Drugs mentioned

• Aprepitant (aprepitant)
• Ondansetron (ondansetron)

Snippet

Sponsor: Sergio Bergese | Conditions: Postoperative Nausea and Vomiting (PONV), Nausea | Phase 4 | Status: COMPLETED | Results posted: 2013-12-03